Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trialVolker Kunzmann, Wolfgang Blau, Hana Algül et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 202